Singapore, May 7 -- US-based Flagship Pioneering, a bioplatform innovation company, the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), National University Hospital (NUH) and the National University Health System (NUHS) have announced a research and development collaboration to advance outcomes in human health and sustainability. A Memorandum of Understanding (MoU) was signed by Flagship, NUS Medicine, NUH and NUHS outlining their collaboration goals.

Flagship, NUS Medicine, NUH and NUHS expect to create, co-develop and co-resource a series of research projects over an initial five-year horizon, tapping into opportunities across Flagship's existing ecosystem of over 40 companies, and future companies fou...